Monday September 23, 2024 from 12:25 to 13:25
Üsküdar 1&2
Organized by Takeda Pharmaceutical Company Limited.
This exciting and educational symposium will explore the practical challenges currently faced when managing CMV in transplant recipients. Using real-world patient cases and new clinical trial data, we will discuss how new therapies could influence clinical practice to advance patient outcomes in the CMV treatment landscape.